The prognostic value of positron emission tomography performed after two courses (INTERIM-PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL)

International Validation Study for Interim PET in ABVD-Treated, Advanced-Stage Hodgkin Lymphoma: Interpretation Criteria and Concordance Rate Among Reviewers

(2013) A. Biggi et al.   JOURNAL OF NUCLEAR MEDICINE

Treatment for Early-Stage Hodgkin Lymphoma: Has Radiotherapy Had Its Day?

(2012) John Radford   JOURNAL OF CLINICAL ONCOLOGY

Dose-Intensification in Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial

(2012) Bastian von Tresckow et al.   JOURNAL OF CLINICAL ONCOLOGY

Interim positron emission tomography and clinical outcome in patients with early stage Hodgkin lymphoma treated with combined modality therapy

(2012) Andrea Riccardo Filippi et al.   LEUKEMIA & LYMPHOMA

Interim [18F]fluorodeoxyglucose positron emission tomography imaging in stage I–II non-bulky Hodgkin lymphoma: would using combined positron emission tomography and computed tomography criteria better predict response than each test alone?

(2012) Lale Kostakoglu et al.   LEUKEMIA & LYMPHOMA

Report on the Third International Workshop on Interim Positron Emission Tomography in Lymphoma held in Menton, France, 26–27 September 2011 and Menton 2011 consensus

(2012) Michel Meignan et al.   LEUKEMIA & LYMPHOMA

Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET

(2011) D. J. Straus et al.   BLOOD

Early interim 18F-FDG PET in Hodgkin’s lymphoma: evaluation on 304 patients

(2011) Pier Luigi Zinzani et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin's lymphoma

(2010) J. A. Barnes et al.   ANNALS OF ONCOLOGY

A functional dynamic scoring model to elucidate the significance of post-induction interim fluorine-18-fluorodeoxyglucose positron emission tomography findings in patients with Hodgkin's lymphoma

(2010) E. J. Dann et al.   HAEMATOLOGICA

Intensified Chemotherapy and Dose-Reduced Involved-Field Radiotherapy in Patients With Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD11 Trial

(2010) Hans Theodor Eich et al.   JOURNAL OF CLINICAL ONCOLOGY

Current clinical evidence on interim fluorine-18 fluorodeoxy glucose positron emission tomography for advanced-stage Hodgkin lymphoma and diffuse large B-cell lymphoma to predict treatment outcomes

(2010) Teruhiko Terasawa et al.   LEUKEMIA & LYMPHOMA

Interim positron emission tomography scan in Hodgkin lymphoma: definitions, interpretation rules, and clinical validation

(2010) Andrea Gallamini et al.   LEUKEMIA & LYMPHOMA

Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma

(2010) Andreas Engert et al.   NEW ENGLAND JOURNAL OF MEDICINE